Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,244
  • Shares Outstanding, K 35,884
  • Annual Sales, $ 4 K
  • Annual Income, $ -124,120 K
  • 60-Month Beta 1.09
  • Price/Sales 5,732.47
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BIOR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.44
  • Most Recent Earnings $-0.63 on 03/26/24
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 223.63% ( -8.11%)
  • Historical Volatility 131.47%
  • IV Percentile 91%
  • IV Rank 58.61%
  • IV High 368.67% on 01/18/24
  • IV Low 18.27% on 01/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 107
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 3,248
  • Open Int (30-Day) 7,076

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.45
  • Number of Estimates 1
  • High Estimate -0.45
  • Low Estimate -0.45
  • Prior Year -1.59
  • Growth Rate Est. (year over year) +71.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5850 +3.23%
on 04/18/24
1.3300 -54.59%
on 03/26/24
-0.6161 (-50.50%)
since 03/25/24
3-Month
0.5850 +3.23%
on 04/18/24
1.9900 -69.65%
on 02/28/24
-0.3131 (-34.14%)
since 01/25/24
52-Week
0.5850 +3.23%
on 04/18/24
6.7000 -90.99%
on 06/09/23
-1.9261 (-76.13%)
since 04/25/23

Most Recent Stories

More News
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?

Here is how Butterfly Network, Inc. (BFLY) and Biora Therapeutics, Inc. (BIOR) have performed compared to their sector so far this year.

BFLY : 0.7140 (+0.99%)
BIOR : 0.6039 (-2.58%)
Biora Therapeutics, Inc. (BIOR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Biora Therapeutics, Inc. (BIOR), indicating that the stock has found support. This, combined with an upward trend in earnings...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics, Inc. (BIOR) Reports Q3 Loss, Misses Revenue Estimates

Biora Therapeutics, Inc. (BIOR) delivered earnings and revenue surprises of -33.33% and 20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

BIOR : 0.6039 (-2.58%)
VREX : 16.80 (-1.64%)
Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of 7.53% and 2.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

FATE : 3.96 (-7.91%)
BIOR : 0.6039 (-2.58%)
Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform

All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022

SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics to Participate in Upcoming BTIG Investment Conference

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics (BIOR) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Biora Therapeutics (BIOR – Research Report) today and set a price target of $6.00. The company's shares closed last Thursday at $0.71,...

BIOR : 0.6039 (-2.58%)
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022

Demonstrates OBDS Device Performance and Bioavailability in Animal Models...

BIOR : 0.6039 (-2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 0.6966
2nd Resistance Point 0.6733
1st Resistance Point 0.6466
Last Price 0.6039
1st Support Level 0.5966
2nd Support Level 0.5733
3rd Support Level 0.5466

See More

52-Week High 6.7000
Fibonacci 61.8% 4.3641
Fibonacci 50% 3.6425
Fibonacci 38.2% 2.9209
Last Price 0.6039
52-Week Low 0.5850

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar